1 – 10 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Surveillance after resection of pancreatic ductal adenocarcinoma : How to do it and what are the benefits?
2024) In Scandinavian Journal of Surgery(
- Contribution to journal › Article
-
Mark
L-type Amino Acid Transporter 1 as a Therapeutic Target in Pancreatic Cancer
(
- Contribution to journal › Debate/Note/Editorial
- 2023
-
Mark
Model-based screening for pancreatic cancer in Sweden
(
- Contribution to journal › Article
- 2022
-
Mark
Surgical resection of pancreatic cancer with synchronous hepatic oligometastases : Real benefit or selection bias?
(
- Contribution to journal › Letter
- 2021
-
Mark
Organoid technology for personalized pancreatic cancer therapy
(
- Contribution to journal › Scientific review
-
Mark
Projected economic burden of pancreatic cancer in Sweden in 2030
(
- Contribution to journal › Article
- 2020
-
Mark
Potential biomarkers for early detection of pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
(
- Contribution to journal › Article
-
Mark
Proteomic and genomic profiling of pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article